Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 07/1/17 → 06/30/18 |
Funding
- Janssen Research and Development LLC: $937.50
ESKETINTRD3003 Start Up Costs: A Randomized, Double-blind, Multicenter, Active-controlled Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Treatment-resistant Depression
- DeLorenzo, Christine (PI)
Project: Research